Results 181 to 190 of about 221,455 (333)

Expert Perspectives: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies

Arthritis &Rheumatology, EarlyView.
Treat‐to‐target has transformed the management of several rheumatic diseases through predefined therapeutic goals, structured disease assessment, and timely treatment adjustment. Despite major advances in the understanding and treatment of idiopathic inflammatory myopathies (IIM), a formal treat‐to‐target framework for adult IIM has not yet been ...
Shiri Keret, Nantakarn Pongtarakulpanit, Rohit Aggarwal   +2 more
wiley   +1 more source

Rituximab use in adult primary glomerulopathy: where is the evidence?

, 2016
Samir G Mallat,1 Houssam S Itani,2 Rana M Abou-Mrad,3 Rima Abou Arkoub,4 Bassem Y Tanios1 1Division of Nephrology, Department of Internal Medicine, American University of Beirut Medical Center, 2Division of Nephrology, Department of Internal Medicine ...
Mallat SG, Abou-Mrad RM, Itani HS, Abou Arkoub R, Tanios BY   +4 more
core  

Treatment‐Driven Peripheral Blood Transcriptomic Remodeling and Baseline Predictors of ESSDAI and STAR Response to B Cell Therapy in Sjögren's Disease

Arthritis &Rheumatology, EarlyView.
Graphical Abstract Objective This study aimed to characterize whole blood transcriptomic profiles in adults with active Sjögren's disease (SjD) treated with anti‐CD20 or B lymphocyte stimulator/BAFF inhibition, identify markers of clinical response, and define inflammatory pathways linked to nonresponse. Methods Whole blood RNA sequencing was performed
Aimen Ibrahim, Junjie Peng, Eileen Tian, Lucia Martin‐Gutierrez, John Casement, Kyle Thompson, Wan‐Fai Ng, André van Maurik, Elizabeth C. Jury, Coziana Ciurtin   +9 more
wiley   +1 more source

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis

, 2015
Shivani Shah, Duvuru Geetha Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Abstract: Granulomatosis with polyangiitis and microscopic polyangiitis are small vessel vasculitides ...
Shah S, Geetha D
core  

Use of rituximab in the treatment of pemphigus vulgaris in a juvenile patient

Introduction: Pemphigus vulgaris is a chronic autoimmune blistering disorder characterised by the production of autoantibodies against desmogleins, resulting in intraepithelial blister formation.
Rafał Białynicki-Birula, Wojciech Baran, Hanna Róża Cisoń   +2 more
core   +1 more source

Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data.

Arthritis &Rheumatology, Accepted Article.
Background Little is known about the prevalence of and factors associated with Long COVID in patients with autoimmune rheumatic diseases (AIRDs). Methods We conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C).
Namrata Singh, A. Jerrod Anzalone, Holland Stevenson, Londyn Robinson, Lesley E. Jackson, Sandra E. Safo, Zachary Butzin‐Dozier, Kaleb Michaud, Maria I. Danila, Jasvinder A. Singh, Rena C. Patel, on behalf of the National Clinical Cohort Collaborative (N3C) Consortium   +11 more
wiley   +1 more source

Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma

, 2015
David Aguiar-Bujanda, María Jesús Blanco-Sánchez, María Hernández-Sosa, Saray Galván-Ruíz, Samuel Hernández-Sarmiento Department of Medical Oncology, Hospital Universitario de Gran Canaria Doctor ...
Aguiar-Bujanda D, Blanco-Sánchez MJ, Galván-Ruíz S, Hernández-Sarmiento S, Hernández-Sosa M   +4 more
core  

Plasmapheresis for Facilitating Readministration of Rituximab After Paradoxical Exacerbation in Pemphigus Vulgaris: A Case Report

Clinical Case Reports
Rare reports of post‐rituximab exacerbation of pemphigus vulgaris (PV) have been published, with some therapeutic protocols proposed for managing this condition.
Mohammad Reza Pourani, Sayyed Mojtaba Nekooghadam, Fatemeh Samadi, Sanaz Soleimani, Fahimeh Abdollahimajd   +4 more
doaj   +1 more source

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2018
J. Seymour, T. Kipps, B. Eichhorst, P. Hillmen, J. D'Rozario, S. Assouline, C. Owen, J. Gerecitano, T. Robak, J. de la Serna, U. Jaeger, G. Cartron, M. Montillo, R. Humerickhouse, E. Punnoose, Yan Li, M. Boyer, K. Humphrey, M. Mobasher, A. Kater   +19 more
semanticscholar   +1 more source

Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression

, 2019
Lina Song,1,2 Wei Zhang,3 Hong Chen,4 Xizhi Zhang,1 Haoan Wu,1 Ming Ma,1 Zhongqiu Wang,2 Ning Gu,1 Yu Zhang1 1State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical ...
Song L, Zhang W, Ma M, Zhang Y, Zhang X, Chen H, Wang Z, Gu N, Wu H   +8 more
core